Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
May 15, 2014 (Vol. 34, No. 10)

Cell Trials

URL:celltrials.info
  • Clean site design, frequently updated
  • Cannot browse by topic

Cells—miraculous little things, wouldn’t you say? As the building blocks of all living things, cells are increasingly finding time in the spotlight due to their clinical importance. Not only can they be grown in cultures, they can also be grown in the lab to make organs and can also be given directly to patients as cell therapy treatments. The Cell Trials website lets readers stay up-to-date on the latest in the cell therapy field through blog posts about cell therapy clinical trials, stem cell research, regenerative medication, and other related topics. The site is cleanly designed and minimalist, presenting the blog articles in chronological order, with the newest at the top of the page. The right-hand menu bar allows users to click to “featured posts” or recently made comments, although there is no option to view posts related to a given topic. Instead, one can only enter keywords in the search field.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »